Inflammation plays a central role in the manner that the nervous system responds to injury. These effects include vasodilatation, increased vascular permeability, plasma extravasation, cell migration, and pain. Extracellular signals associated with inflammation may also lead to increased levels of pro-nociceptive chemokines/receptors that directly contribute to persistent or chronic pain behavior. To date, research focused on improving the treatment of chronic pain has largely ignored the role of inflammation-associated transcription factors such as nuclear transcription factor in activated T cells (NFAT). Herein we discuss the idea that activation of this transcription factor may be responsible for the production of chemokines receptors in both neuronal and non-neuronal cells of the peripheral nervous system. Taken together, a better understanding of the transcription of these pro-nociceptive genes may lead to the development of novel analgesic targets.
Introduction
Peripheral nerve injury triggers a wide variety of cellular changes in the neurons of the associated sensory ganglia and is frequently accompanied by nociceptive behavior such as tactile allodynia (pain in response to light touch/pressure) and hyperalgesia (an increased sensitivity to pain). It has been proposed that these ongoing symptoms are due to enhanced excitability or sensitization of primary afferents in the dorsal root ganglia (DRG) (Devor, 2009; Ma et al., 2003; Suter et al., 2009) . In turn, signal amplification by hyperexcitable sensory neurons may trigger changes in the response pattern of spinal cord dorsal horn neurons, a mechanism also known as central sensitization (Woolf, 1983; Woolf and Thompson, 1991) . Although it is clear that molecular and possibly anatomical changes in the spinal cord dorsal horn are responsible for some attributes of chronic pain, primary afferent neuron-associated discharge is critical to the development and maintenance of chronic inflammatory or neuropathic pain.
One mechanism in which somatosensory afferent neurons may be induced to exhibit enhanced excitability following nerve injury is through the action of proalgesic inflammatory mediators (Miller et al., 2009 ). These include pro-inflammatory cytokines such as tumor necrosis factor-a (TNFa) and interleukin-1b (IL-1b), growth factors such as nerve growth factor (NGF) and other mediators such as prostaglandins or adenosine triphosphate (ATP), all of which can induce peripheral sensitization. The release of these factors by cells such as leukocytes in damaged peripheral targets or glial cells in damaged nerves may directly excite sensory neurons or induce the production of further mediators of peripheral sensitization: the chemokines. As we shall discuss, numerous chemokines have been shown to produce excitatory effects on cultured (Oh et al., 2001 ) and previously injured adult DRG sensory neurons and may act as downstream mediators of increased neuronal excitability (Bhangoo et al., 2007a (Bhangoo et al., , 2009 Jung et al., 2009; Sun et al., 2006; White et al., 2005) .
Chemokines and chemokine receptors
Chemokines constitute a large family of relatively low molecular weight proteins classified by the presence of a cysteine motif in the N-terminal region of the protein. Initial characterization of chemokines divided the family into a-and b-chemokines. In a-chemokines, one amino acid separates the first two cysteine residues (cysteine-X amino acid-cysteine or CXC), whereas in b-chemokines, the first two cysteine residues are adjacent to each other (cysteine-cysteine or CC). Two additional classes were added for the chemokines, lymphotactin (single cysteine, XC), and fractalkine
